PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application-A Literature Review.

Cancers (Basel) · 2023 · PMC9913570 · PMID 36765866

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

showed a trend for increasing SUVmax values from Luminal A (lower values) to Luminal B HER2-positive type and HER2-enriched tumors (higher values); moreover, HER2 expression seems to confer the highest 68 Ga-FAPI activity among the Luminal group, with significantly higher uptake in Luminal B HER2-positive vs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.